Captivision (CAPT) receives Nasdaq notice on late 20-F

Captivision Inc. (“Captivision” or the “Company”) (NASDAQ: CAPT), a pioneering manufacturer and global LED solution provider, today announced that it received a letter (the “Letter”) on May 22, 2025, from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company is not in compliance with Nasdaq Listing Rule 5250(c)(1) because it has not yet filed its Annual Report on Form 20-F for the period ended December 31, 2024 (the “Form 20-F”) with the Securities and Exchange Commission (the “SEC”). The Letter is only a notification of deficiency, not of imminent delisting, and has no current effect on the listing or trading of the Company’s securities on the Nasdaq Stock Market. The Letter is in addition to previously disclosed letters regarding the Company’s non-compliance with Nasdaq’s continued listing standards related to market value of publicly held shares, minimum bid price, and market value of listed securities.

In accordance with Nasdaq Listing Rules, the Company has 60 calendar days (until July 21, 2025) to submit a plan to regain compliance. If Nasdaq accepts the Company’s plan, Nasdaq can grant an exception of up to 180 calendar days from the due date of the Form 20-F, or until November 11, 2025, to regain compliance. However, there can be no assurance that Nasdaq will accept the Company’s plan to regain compliance or that the Company will be able to regain compliance within any extension period granted by Nasdaq. If Nasdaq does not accept the Company’s plan, the Company will have the opportunity to appeal that decision to a Hearing Panel under Nasdaq Listing Rule 5815(a). If the Company fails to timely regain compliance with Nasdaq’s listing rules, the securities of the Company will be subject to delisting on Nasdaq.

The Company is continuing to work diligently to finalize and file the Form 20-F as soon as possible within the timeline prescribed by Nasdaq. However, there can be no assurance that the Company will be able to file the Form 20-F within any applicable cure period.

This announcement is made in compliance with Nasdaq Listing Rule 5810(b), which requires prompt disclosure of receipt of a deficiency notification.

You May Also Be Interested In

• HIVE's BUZZ HPC signs $350M five-year AI cloud services deal
• Realty Income closes $1B convertible notes offering
• XTEND positions itself for U.S. drone tariff market shift